NZX Governance Explorer

Abigail Rotheroe

Abigail Rotheroe was appointed as a Director with effect from 1 November 2022. Abigail has over 20 years of investment experience, most recently as the Investment Director at Snowball Impact Management, a sustainable and impact-focused asset manager. Previously Abigail managed retail and institutional Asia Pacific portfolios in Hong Kong and London for Schroders, HSBC Asset Management and Columbia Threadneedle Investments. She is a CFA Charterholder and has experience in manager selection, sustainability, and impact measurement.

Current Positions

  • at AFT Pharmaceuticals Limited (issuer)
  • MD — Co-Founder and Managing Director at AFT Pharmaceuticals Limited (executive)
  • CEO — Chief Executive Officer at AFT Pharmaceuticals Limited (executive)
Loading profile...
About this profile

This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.

Source registers used on this page
  • NZX market announcements and continuous-disclosure filings
  • Audited annual reports lodged with NZX
  • FMA Disclose Register (substantial product holders, insider trades)
  • NZ Companies Office records (Companies Act 1993 §215)
  • NZ Government Gazette appointment notices
  • Issuer earnings webcasts and investor presentations

If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.